Eutylone (also known as β-keto-1,3-benzodioxolyl-N-ethylbutanamine, bk-EBDB, and N-ethylbutylone) is a stimulant and empathogenic drug of the phenethylamine, amphetamine, phenylisobutylamine, and cathinone families. It was developed in the 1960s and first reported to the EMCDDA in 2014. Eutylone is a designer drug which became widespread internationally in 2019–2020 following bans on the related compound ephylone. It is a synthetic cathinone. In 2021, eutylone was the most common cathinone identified by the Drug Enforcement Administration in the United States.
Pharmacology +IC50 inhibition values at monoamine transporters (nM) 120 ± 10 1280 ± 140 690 ± 50
Legal status Sweden's public health agency suggested classifying eutylone as a hazardous substance on September 25, 2019.
In the United States Eutylone is considered a schedule 1 controlled substance as a positional isomer of Pentylone.Lists of: Scheduling Actions. Controlled Substances. Regulated Chemicals
See also Substituted methylenedioxyphenethylamine 5-Methylethylone Butylone Ethyl-J Ethylone Ephylone N-Ethylhexedrone N-Ethylhexylone N-Ethylheptylone
References